The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease

• Main Authors: Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli
• Format: Article
• Language: English
• Published: IMR (Innovative Medical Research) Press Limited 2021-09-01
• Series: Reviews in Cardiovascular Medicine
• Subjects: heart failure; hypertrophic cardiomyopathy; dilated cardiomyopathy; ischemic cardiomyopathy; valvular heart disease; covid-19; telemedicine; heart failure outpatient programs
• Online Access: https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453065083-1418249639.pdf

Heart Failure (HF) is characterized by an elevated readmission rate, with almost 50% of events occurring after the first episode over the first 6 months of the post-discharge period. In this context, the vulnerable phase represents the period when patients elapse from a sub-acute to a more stabilized chronic phase. The lack of an accurate approach for each HF subtype is probably the main cause of the inconclusive data in reducing the trend of recurrent hospitalizations. Most care programs are based on the main diagnosis and the HF stages, but a model focused on the specific HF etiology is lacking. The HF clinic route based on the HF etiology and the underlying diseases responsible for HF could become an interesting approach, compared with the traditional programs, mainly based on non-specific HF subtypes and New York Heart Association class, rather than on detailed etiologic and epidemiological data. This type of care may reduce the 30-day readmission rates for HF, increase the use of evidence-based therapies, prevent the exacerbation of each comorbidity, improve patient compliance, and decrease the use of resources. For all these reasons, we propose a dedicated outpatient HF program with a daily practice scenario that could improve the early identification of symptom progression and the quality-of-life evaluation, facilitate the access to diagnostic and laboratory tools and improve the utilization of financial resources, together with optimal medical titration and management.